NCT04437004Approved For Marketing不适用

Treatment of Dravet Syndrome With Fenfluramine (Expanded Access Protocol)

University of California, Los Angeles1 个研究点分布在 1 个国家开始时间: 2020年6月18日最近更新: 2026年4月20日

研究概览

简要总结

The purpose of this research study is to (1) provide access to fenfluramine for patients with intractable epilepsy associated with Dravet syndrome, and (2) evaluate the safety of fenfluramine.

详细描述

The purpose of this research study is to (1) provide access to fenfluramine for patients with intractable epilepsy associated with Dravet syndrome, and (2) evaluate the safety of fenfluramine.

研究设计

研究类型: Expanded Access

入排标准

年龄范围: 2 Years 至 —（Child, Adult, Older Adult）
性别: All
接受健康志愿者: 否

入选标准

•Genetic diagnosis of Dravet syndrome with intractable seizures despite failing all available medications for seizures.

排除标准

未提供

研究者

发起方

University of California, Los Angeles

申办方类型

Other

责任方

Sponsor

主要研究者

Shaun Hussain, MD

Associate Professor

University of California, Los Angeles

研究点 (1)

Loading locations...

相似试验

进行中（未招募）

1 期

Fenfluramine as anti-epilepticum in a difficult to treat epilepsy syndrome.Fenfluramine is an amphetamine which was in the past used as anorexigan. Their are a few publications of effectivness of this medication in epilepsy.We want to investigate was is the exact place of fenfluramine in the treatment of a therapy resitant epilepsy named Dravet syndrome.MedDRA version: 21.0Level: PTClassification code 10015037Term: EpilepsySystem Organ Class: 10029205 - Nervous system disorders

EUCTR2011-004114-42-BEniversity Hospital Antwerp50

招募中

4 期

Assessment of Safety of the Use of Fenfluramine in Children With Dravet Syndrome Under 24 Months of AgeDravet Syndrome (DS)Children Under 2 Years

NCT06598449University of Colorado, Denver12

尚未招募

3 期

Fenfluramine for Adult Dravet PatientsDravet SyndromeDravet Syndrome, Intractable

NCT05560282University Health Network, Toronto15

招募中

4 期

Fenfluramine for the Treatment of Different Types of Developmental and Epileptic Encephalopathies: a Pilot Trial Exploring Epileptic and Non-epileptic OutcomesSYNGAP1 EncephalopathyRefractory EpilepsySTXBP1 Encephalopathy With EpilepsyInv Dup(15) EncephalopathyMultifocal or Bilateral Malformations of Cortical DevelopmentContinuous Spike and Waves During Slow Sleep

NCT05232630Hospital Ruber Internacional20

进行中（未招募）

1 期

The FENDEEP Study: Fenfluramine for the treatment of different types of developmental and epileptic encephalopathies: a pilot trial exploring epileptic and non-epileptic outcomes. - The FENDEEP Study

EUCTR2021-002821-32-ESeurologia Aplicada, SLP20